Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate vs Drug Holiday in Osteoporosis
NCT01512446Phase 3Terminated
- Start
- Feb 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Alendronate with Placebo (2 arms). Primary endpoint: Number of New Osteoporotic Fractures. Started Feb 2012; status: terminated.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01512446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01512446.